FBR Capital

Analysts at FBR Capital initiated coverage on Zafgen Inc (NASDAQ: ZFGN) with a Outperform rating. The target price for Zafgen is set to $60. Zafgen's shares rose 3.16 percent to close at $36.58 yesterday.

FBR Capital initiated coverage on Genocea Biosciences Inc (NASDAQ: GNCA) with a Outperform rating. The target price for Genocea Biosciences is set to $20. Genocea Biosciences shares have dropped 35.12 percent over the past 52 weeks, while the S&P 500 index has surged 11.75 percent in the same...

Analysts at FBR Capital initiated coverage on Regulus Therapeutics Inc (NASDAQ: RGLS) with a Outperform rating. The target price for Regulus Therapeutics is set to $30. Regulus Therapeutics shares have gained 133.42 percent over the past 52 weeks, while the S&P 500 index has surged 11.75...

FBR Capital upgraded Netflix, Inc. (NASDAQ: NFLX) from Market Perform to Outperform. The price target for Netflix has been raised from $400 to $900. Netflix shares have gained 37.52% over the past 52 weeks, while the S&P 500 index has surged 12.97% in the same period. Netflix shares climbed 12....

Analysts at FBR Capital downgraded Annaly Capital Management, Inc. (NYSE: NLY) from Market Perform to Underperform. The price target for Annaly Capital Management has been lowered from $12.00 to $10.00. Annaly Capital Management shares have dropped 8.44% over the past 52 weeks, while the S&P...

Analysts at FBR Capital initiated coverage on Demandware, Inc. (NYSE: DWRE) with a Outperform rating. The target price for Demandware is set to $70. Demandware shares have gained 8.52% over the past 52 weeks, while the S&P 500 index has surged 10.90% in the same period. Demandware's shares rose...

Analysts at FBR Capital initiated coverage on Pacific DataVision, Inc. (NASDAQ: PDVW) with a Outperform rating. The target price for Pacific DataVision is set to $77. Pacific DataVision's shares rose 0.99% to close at $49.99 yesterday.

Analysts at FBR Capital downgraded Gannett Co., Inc. (NYSE: GCI) from Outperform to Market Perform. The price target for Gannett is set to $38. Gannett shares have gained 35.82% over the past 52 weeks, while the S&P 500 index has surged 10.82% in the same period. Gannett's shares climbed 1.58%...

Analysts at FBR Capital downgraded FMC Technologies, Inc. (NYSE: FTI) from Market Perform to Underperform. The price target for FMC Technologies has been lowered from $50.00 to $31.00. FMC Technologies shares have dropped 25.89% over the past 52 weeks, while the S&P 500 index has surged 9.42%...

FBR Capital upgraded UTi Worldwide, Inc. (NASDAQ: UTIW) from Market Perform to Outperform. The price target for UTi Worldwide has been raised from $11.00 to $19.00. UTi Worldwide shares have gained 10.25% over the past 52 weeks, while the S&P 500 index has surged 10.34% in the same period. UTi...

Analysts at FBR Capital downgraded Crane Co. (NYSE: CR) from Outperform to Market Perform. The price target for Crane has been lowered from $77.00 to $67.00. Crane shares have dropped 4.31% over the past 52 weeks, while the S&P 500 index has surged 13.51% in the same period. Crane's shares fell...

FBR Capital upgraded Marvell Technology Group Ltd. (NASDAQ: MRVL) from Market Perform to Outperform. The price target for Marvell Technology Group has been raised from $19.00 to $21.00. Marvell Technology Group shares have gained 5.13% over the past 52 weeks, while the S&P 500 index has surged...

Analysts at FBR Capital upgraded Monster Worldwide, Inc. (NYSE: MWW) from Market Perform to Outperform. The price target for Monster Worldwide has been raised from $4.50 to $6.80. Monster Worldwide shares have dropped 30.77% over the past 52 weeks, while the S&P 500 index has surged 13.71% in...

Analysts at FBR Capital downgraded Visa Inc. (NYSE: V) from Outperform to Market Perform. The price target for Visa is set to $260. Visa shares have gained 15.12% over the past 52 weeks, while the S&P 500 index has surged 13.39% in the same period. Visa shares rose 3.91% to $257.70 in pre-...